বাংলায় দেখুন
Hepatab

Hepatab

Tablet

🧬 Rifaximin 🏢 Ibn Sina Pharmaceuticals Ltd.
Generic Name Rifaximin
Manufacturer Ibn Sina Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 20.00 (2 x 10: ৳ 400.00) Strip Price: ৳ 200.00
Unit Price: ৳ 20.00 (2 x 10: ৳ 400.00) Strip Price: ৳ 200.00 ✅ In Stock per unit · Bangladesh
🛒 Buy Now

🔒 Secure checkout  ·  Return & Refund Policy

🔹 Indications

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Pharmacology

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Dosage & Administration

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Interaction

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Contraindications

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Side Effects

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Pregnancy & Lactation

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

🔹 Precautions & Warnings

Hepatab is indicaed in-
  • Treatment of traveler's diarrhea by noninvasive strains of E. coli
  • reduction in risk of overt hepatic encephalopathy
  • bacterial overgrowth of irritable bowel syndrome.

💡 Frequently Asked Questions

Hepatab is indicaed in- Treatment of traveler's diarrhea by noninvasive strains of E. coli reduction in risk of overt hepatic encephalopathy bacterial overgrowth of irritable bowel syndrome.
Hepatab is indicaed in- Treatment of traveler's diarrhea by noninvasive strains of E. coli reduction in risk of overt hepatic encephalopathy bacterial overgrowth of irritable bowel syndrome.
Hepatab is indicaed in- Treatment of traveler's diarrhea by noninvasive strains of E. coli reduction in risk of overt hepatic encephalopathy bacterial overgrowth of irritable bowel syndrome.

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review